Cite Filings / BCRX / 0001104659-18-015945
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
425

Prospectus/Communication re Business Combination

BIOCRYST PHARMACEUTICALS INC · Filed 2018-03-08 · Acc 0001104659-18-015945

Documents 1

  • 425 Prospectus/Communication re Business Combination , a18-7748_2425.htm

Around this filing

  • 2018-03-22 425 Prospectus/Communication re Business Combination
  • 2018-03-12 10-K Annual Report
  • 2018-03-08 4 Senior VP - Drug Discovery gave up 21,125 shares (to pay taxes)
  • 2018-03-08 425 Prospectus/Communication re Business Combination
  • 2018-03-07 425 Prospectus/Communication re Business Combination
  • 2018-03-02 4 President & CEO gave up 43,224 shares (to pay taxes)
  • 2018-03-02 4 Director acquired 2,012 shares (grant or award)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading a18-7748_2425.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…